Showing 91-100 of 1620 results for "".
Meibomian Gland Probing
https://modernod.com/podcasts/to-the-point/meibomian-gland-probing/36941/This month on To the Point, learn about meibomian gland probing in patients with dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. Their guest, Rana Taji, OD, MSc, FAAO, explains what it is, how to do it, why to do it, and more.Treating Dry Eye at the Molecular Level
https://modernod.com/podcasts/to-the-point/treating-dry-eye-at-the-molecular-level/36939/Jacob Lang, OD, FAAO, shares his knowledge of innovative therapies for dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. He discusses drugs in development that target pathways involved in ocular surface disease, such as reactive aldehyde species inhibitors, transient receThe Changing Landscape of Dry Eye Disease
https://modernod.com/podcasts/to-the-point/the-changing-landscape-of-dry-eye-disease/36912/In this episode of To the Point, Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO, are joined by Kelly K. Nichols, OD, MPH, PhD, FAAO, who shares her knowledge of novel dry eye therapies in the pipeline. Dr. Nichols also discusses what optometrists can look forward to in the next couple of yearMaking the Move to an Aesthetic Practice
https://modernod.com/podcasts/to-the-point/making-the-move-to-an-aesthetic-practice/36910/Hosts Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO, talk practice management strategies with guest Melanie Denton, OD, MBA, FAAO. Dr. Denton outlines the pros of earning an MBA, the steps she took in opening her practice and adding aesthetics, how to hire consultants, and general patient beEyelash Enhancements • IPL Therapy
https://modernod.com/podcasts/the-mod-pod/eyelash-enhancements-ipl-therapy/36860/Check out the latest episode of The MOD Pod, where Cecelia Koetting, OD, FAAO, Dipl ABO, has an engaging conversation with Jason E. Compton, OD, FAAO, and Mahnia Madan, OD, FAAO, about their article on eyelash enhancements, which appears in the May/June issue Modern Optometry. In the second half ofPresbyopia Drops • Glaucoma Diagnostics • Specialty Lenses
https://modernod.com/podcasts/the-mod-pod/presbyopia-drops-glaucoma-diagnostics-specialty-lenses/36822/Rachael A. Wruble, OD, FAAO, leads off the episode with a discussion on how presbyopia-correcting drops will fit into the treatment toolbox (00:45). Daniel Epshtein, OD, FAAO, and co-author Patricia Fulmer, OD, FAAO, follow with a survey of new and next-generation technologies and devices in their pPresbyopia • Dry Eye • Staff Management • OD Profiles
https://modernod.com/podcasts/the-mod-pod/presbyopia-dry-eye-staff-management-od-profiles/36799/Mark Schaeffer, OD, offers guidance for handling presbyopic patients who have never before needed vision correction (0:50). Rebecca Miller, OD, gives advice on how to incorporate autologous serum eye drops into a dry eye protocol (7:58). Get five pearls for improving employee relationships and elimiA Winding Path Leads to Career Satisfaction
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-oct-2022-video/37317/Joseph J. Allen, OD, FAAO, Dipl ABO, interviews Justin Manning, OD, MPH, FAAO, about his journey from optometric clinical practice to industry. The move to industry starts with building your network, and you can do this by engaging with sales representatives who visit your clinic and industry partneHow to Fit an Orthokeratology Lens
https://modernod.com/videos/eye-care-insiders/eci-april-2022-video/37311/Joseph J. Allen, OD, FAAO, Dipl ABO, is joined by Trevor Fosso, OD, FAAO, FSCS, to discuss how to get started with fitting orthokeratology (ortho-k) lenses. The two physicians break down different designs of ortho-k lenses, describe how to identify which patients are the best candidates, and share tThe Near Future in Managing Dry Eye Disease
https://modernod.com/topics/corneaanterior-segment/the-near-future-in-managing-dry-eye-disease-1/36877/Cecelia Koetting, OD, FAAO, DipABO, and Marc Bloomenstein, OD, FAAO, convened to discuss the current state of ocular surface disease, including the progressive nature, patient communication and symptoms, new and upcoming therapies, and more.